FDA offers supplementary clearances to Bio-Rad’s IH-System Gel Reagents, Blood Typing Products Read more
AstraZeneca and Merck asserted the approval of LYNPARZA tablets for patients with Ovarian Cancer Read more
Ligand Pharmaceuticals initiates a program to develop contrast agents for Diagnostic Imaging Read more